Scrip
Pfizer's Geodon gets go-ahead for new indication in the US
23 November 2009
Asher Mullard
Please Login to read the full article.
23 November 2009
Asher Mullard
The US FDA has expanded the label for Pfizer's Geodon (ziprasidone HCl) to include maintenance treatment of bipolar disorder in adults, as an adjunct therapy to lithium and valproate.
Ziprasidone HCl – an atypical antipsychotic 5-HT1A agonist – is also approved for treatment...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US panel backs paediatric use of Seroquel and Zyprexa, but splits on Geodon
- J&J's Risperdal Consta approved for bipolar disorder in US
- Seroquel collects more approvals, and a complete response letter, from the US FDA
- US panel endorses Schering-Plough's antipsychotic asenapine
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
